Episode 4 Trial Oversight Spotlight
Yvanne Enever
Founder and CEO, PHARMExcel
Key Points
- Balancing needs of Academic vs Commercial Sponsors
- Financial vs risk-based approaches in oversight
- Preparing for GCP Revision 3 changes
Tom interviews Yvanne Enever, Founder and CEO of PHARMExcel. They delve into building quality partnerships between Sponsors and Service Providers, highlighting the valuable insights gained when things don’t go as planned.
Chapters
About the Guest
Yvanne Enever
Founder and CEO, PHARMExcel
Yvanne Enever, Founder and CEO of PHARMExcel, leads an ISO-accredited CRO for Phase I-IV clinical trials supporting UK academia, biopharma, and medical device organisations.
Previously, Yvanne led and spun out UCL's clinical trials unit and is widely recognised for her contributions, including co-authoring studies in The Lancet and being honoured as Businesswoman of the Year.
Want to discuss vendor oversight?
Book a consultation with Tom Lazenby to explore how Mayet can support your clinical QA needs.